Clinical Trial Detail

NCT ID NCT02538926
Title Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements yes
Sponsors University of Washington
Indications

lymphoma

acute lymphocytic leukemia

Therapies

Imatinib

Rituximab

Cyclophosphamide

Prednisone

Doxorubicin + Etoposide + Vincristine

Asparaginase

Age Groups: adult

Additional content available in CKB BOOST